Michelle S. Siegert Net Worth

Ms. Michelle S. Siegert biography

Michelle S. Siegert is the VP of Fin. and Principal Financial & Accounting Officer at Pulmatrix Inc.

What is the salary of Ms Siegert?

As the VP of Fin. and Principal Financial & Accounting Officer of Pulmatrix Inc, the total compensation of Ms Siegert at Pulmatrix Inc is 390,342$. There are 3 executives at Pulmatrix Inc getting paid more, with Teofilo Raad having the highest compensation of 823,367$.

How old is Ms Siegert?

Ms Siegert is 60, she's been the VP of Fin. and Principal Financial & Accounting Officer of Pulmatrix Inc since . There are 6 older and 8 younger executives at Pulmatrix Inc. The oldest executive at Pulmatrix Inc is Dr. Robert S. Langer Jr., Ph.D., Sc.D., SCD, 72, who is the Founder & Member of Scientific Advisory Board.

What's Ms Siegert's mailing address?

Michelle's mailing address filed with the SEC is C/O PULMATRIX, INC., 99 HAYDEN AVE, , LEXINGTON, MA, 02421.

Insiders trading at Pulmatrix Inc

Over the last 9 years, insiders at Pulmatrix Inc have traded over 4,537,500$ worth of Pulmatrix Inc stock and bought 290,998 units worth 2,002,066$ . The most active insiders traders include Steven Gillis、Terrance Mcguire、Innovative Sciences, Inc. O.... On average, Pulmatrix Inc executives and independent directors trade stock every 92 days with the average trade being worth of 521,728$. The most recent stock trade was executed by David L. Hava on 20 March 2017, trading 2,263 units of PULM stock currently worth 5,001$.

What does Pulmatrix Inc do?

pulmatrix is a clinical stage biotechnology company with an inhaled dry powder platform advancing a new generation of inhaled therapeutics. the platform, called isperse (inhaled small particles easily respirable and emitted), represents a new paradigm in inhaled drug delivery based on unique properties: dense, high drug load engineered particles with highly efficient dispersibility and delivery to the airways. the isperse powders can be used with an array of dry powder inhaler technologies and can be formulated with virtually any drug substance.

Pulmatrix Inc executives and stock owners

Pulmatrix Inc executives and other stock owners filed with the SEC include:

• Teofilo Raad,
  President, Chief Executive Officer, Director
• Teofilo David Raad MBA,
  Pres, CEO & Director
• Teofilo David Raad,
  Pres, CEO & Director
• Michelle S. Siegert,
  VP of Fin. and Principal Financial & Accounting Officer
• Michelle Siegert,
  Vice President - Finance
• Michael Higgins,
  Independent Chairman of the Board
• Timothy McCarthy,
  Investor Relations
• Amit Munshi,
  Independent Director
• Mark Iwicki,
  Independent Director
• Rick Batycky,
  Independent Director
• Christopher Cabell,
  Director
• Todd Bazemore,
  Director
• Dr. Margaret M. Wasilewski M.D.,
  Chief Medical Officer
• Peter Ludlum CMA, MBA,
  Interim CFO and Principal Accounting & Financial Officer
• Dr. Robert S. Langer Jr., Ph.D., Sc.D., SCD,
  Founder & Member of Scientific Advisory Board
• David J. Maki J.D.,
  Advisor
• Dr. Alexander M. Klibanov Ph.D.,
  Founder
• Prof. David A. Edwards,
  Founder & Member of Scientific Advisory Board
• Dr. Robert S. Langer Jr.,
  Founder & Member of Scientific Advisory Board
• Steven Arch Venture Fund Vi...,
  
• David L. Hava,
  Chief Scientific Officer
• Matthew L Sherman,
  Director
• William E. Duke,
  Chief Financial Officer
• Robert W. Clarke,
  Chief Executive Officer
• Steven Gillis,
  Director
• Kurt Graves,
  Director
• Terrance Mcguire,
  Director
• Scott M Rocklage,
  Director
• Richard P. Batycky,
  Director
• Venture Fund Vii, L.P.Arch ...,
  
• James M. Roach,
  Chief Medical Officer
• Terrance Flint Jonathan A P...,
  
• Innovative Sciences, Inc. O...,
  10% owner
• David Maki,
  Director
• Anand Varadan,
  Director
• Margaret Wasilewski,
  Chief Medical Officer